| Literature DB >> 33824751 |
Tarek A Okasha1, Walaa M Sabry1, Nivert H Zaki1, Menan A Rabie1, Yomna A Elhawary1.
Abstract
BACKGROUND: Psychiatric intensive care units (PICU) have become an essential part of psychiatric hospital design worldwide, there are few published data about their effectiveness. AIM: In this study, the characteristics and outcomes of 50 Egyptian patients admitted to the first PICU in the Middle East region between April 2015 and October 2018 were retrospectively examined.Entities:
Keywords: demographic-characteristics; intensive care; outcomes; psychiatric intensive care units; psychiatric units
Year: 2021 PMID: 33824751 PMCID: PMC8008029 DOI: 10.4102/sajpsychiatry.v27i0.1527
Source DB: PubMed Journal: S Afr J Psychiatr ISSN: 1608-9685 Impact factor: 1.550
Characteristics of the sample.
| Variables | Number | % |
|---|---|---|
| Male | 24 | 48 |
| Female | 26 | 52 |
| Schizophrenia | 22 | 44 |
| Bipolar affective disorder | 13 | 26 |
| Acute polymorphic psychosis | 6 | 12 |
| Major depressive disorder | 4 | 8 |
| Schizoaffective disorder | 2 | 4 |
| Anorexia nervosa | 1 | 2 |
| Dementia | 1 | 2 |
| Substance-induced mood | 1 | 2 |
| Psychiatric co-morbidity substance abuse | 1 | 2 |
| Lithium toxicity | 1 | 2 |
| Intellectual disability IQ (50) | 2 | 4 |
| Medical co-morbidity cancer thyroid with lung metastasis | 1 | 2 |
| Diabetes mellitus | 2 | 4 |
| Cerebrovascular stroke | 2 | 4 |
| Deep venous thrombosis | 1 | 2 |
| Anaemia | 2 | 4 |
| Hepatosplenomegaly | 1 | 2 |
| Systemic lupus erythematosus (SLE) | 1 | 2 |
| Hip replacement | 1 | 2 |
| Paraparesis | 1 | 2 |
| Left parietal hematoma | 1 | 2 |
| Epilepsy | 1 | 2 |
Causes of admission.
| Variables | Number | % |
|---|---|---|
| Delirium because of psychiatric cause | 19 | 38 |
| Catatonia | 16 | 32 |
| Neuroleptic malignant syndrome | 1 | 2 |
| One-to-one observation for suicidality | 1 | 2 |
| Blood transfusion for anaemia | 1 | 2 |
| Receiving pulse steroids in systemic lupus erythematosus (SLE) | 1 | 2 |
| Post-operative monitoring | 2 | 4 |
| Vital data monitoring | - | - |
| Uncontrolled atrial fibrillation (AF), haemodynamic instability, blood pressure control | 3 | 6 |
| Receiving proton pump inhibitor (pantoprazole) infusion | 1 | 2 |
| Respiratory problems | 3 | 6 |
| Electrolyte disturbance | 2 | 4 |